We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+6.53%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$763M
AUM Growth
-$3.93M
(-0.51%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-6.31%
Top 10 Holdings %
Top 10 Hldgs %
34.53%
Holding
214
New
2
Increased
36
Reduced
121
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$3.26M |
| 2 |
Biogen
BIIB
|
+$1.95M |
| 3 |
Gilead Sciences
GILD
|
+$1.5M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$1.24M |
| 5 |
CELG
Celgene Corp
CELG
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$7.52M |
| 2 |
CVS Health
CVS
|
+$5.77M |
| 3 |
Rockwell Automation
ROK
|
+$3.51M |
| 4 |
IPG Photonics
IPGP
|
+$2.95M |
| 5 |
J.M. Smucker
SJM
|
+$2.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.83% |
| 2 | Technology | 20.54% |
| 3 | Industrials | 14.4% |
| 4 | Financials | 9.98% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.57T
| $31.6M | 4.15% |
747,612
-48,652
| -6% | -$2.03M |
|
2
Procter & Gamble
PG
$339B
| $31.1M | 4.07% |
338,072
-20,926
| -6% | -$1.88M |
|
3
Mastercard
MA
$493B
| $30.7M | 4.03% |
203,027
-9,649
| -5% | -$1.43M |
|
4
Johnson & Johnson
JNJ
$625B
| $28.6M | 3.75% |
204,889
-13,617
| -6% | -$1.9M |
|
|
5
Rockwell Automation
ROK
$49B
| $28.2M | 3.7% |
143,621
-18,421
| -11% | -$3.51M |
|
6
Novartis
NVS
$297B
| $24.7M | 3.23% |
328,009
-14,027
| -4% | -$1.06M |
|
7
Xylem
XYL
$28.1B
| $24M | 3.15% |
352,141
-26,709
| -7% | -$1.77M |
|
8
Walt Disney
DIS
$181B
| $22.1M | 2.9% |
205,595
-7,047
| -3% | -$726K |
|
9
Alphabet (Google) Class A
GOOGL
$4.33T
| $21.9M | 2.88% |
416,540
-5,280
| -1% | -$273K |
|
10
Canadian National Railway
CNI
$76.6B
| $20.5M | 2.68% |
247,928
-15,516
| -6% | -$1.25M |
|
11
Analog Devices
ADI
$190B
| $20.1M | 2.64% |
225,828
-1,544
| -0.7% | -$137K |
|
12
PayPal
PYPL
$50.5B
| $19.8M | 2.59% |
268,361
-14,519
| -5% | -$1.05M |
|
|
13
IPG Photonics
IPGP
$3.84B
| $19.7M | 2.59% |
92,163
-13,897
| -13% | -$2.95M |
|
|
14
CVS Health
CVS
$122B
| $19.2M | 2.52% |
264,683
-79,360
| -23% | -$5.77M |
|
15
Danaher
DHR
$144B
| $18.6M | 2.44% |
226,061
+8,026
| +4% | +$653K |
|
16
Illumina
ILMN
$28.4B
| $18.3M | 2.39% |
85,945
-1,999
| -2% | -$411K |
|
17
AptarGroup
ATR
$8.61B
| $16.2M | 2.12% |
187,826
-19,930
| -10% | -$1.74M |
|
|
18
Stryker
SYK
$130B
| $16M | 2.1% |
103,610
+21,374
| +26% | +$3.26M |
|
19
Automatic Data Processing
ADP
$108B
| $15.8M | 2.07% |
134,771
-7,472
| -5% | -$854K |
|
20
Abbott
ABT
$187B
| $15.2M | 2% |
266,774
+1,529
| +0.6% | +$84.7K |
|
21
Nike
NKE
$61.9B
| $13M | 1.7% |
207,268
+9,290
| +5% | +$534K |
|
|
22
J.M. Smucker
SJM
$12.8B
| $11M | 1.44% |
88,514
-21,198
| -19% | -$2.36M |
|
23
NVIDIA
NVDA
$5.42T
| $10M | 1.31% |
2,070,920
-87,840
| -4% | -$436K |
|
|
XLNX
24
DELISTED
Xilinx Inc
XLNX
| $9.87M | 1.29% |
146,365
+17,418
| +14% | +$1.24M |
|
25
MarketAxess Holdings
MKTX
$5.72B
| $9.76M | 1.28% |
48,372
-6,200
| -11% | -$1.17M |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Reynders McVeigh Capital Management held 214 positions worth $763M, down 0.51% from $767M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management withdrew a net $48.2M in Q4 2017, closing 12 positions and reducing 121 holdings. Its most notable exit was Kroger, an estimated $1.85M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.
Against the trend, Reynders McVeigh Capital Management opened a new position in DexCom worth $638K.
- Reynders McVeigh Capital Management's largest Q4 2017 buy was DexCom: 44,460 shares worth $638K.
- Reynders McVeigh Capital Management added most to Stryker in Q4 2017, an estimated $3.26M increase.
- Reynders McVeigh Capital Management's biggest Q4 2017 reduction was Johnson Controls International, cutting an estimated $7.52M.
- Reynders McVeigh Capital Management fully exited Kroger in Q4 2017, selling an estimated $1.85M.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $763M portfolio in Q4 2017.
- Reynders McVeigh Capital Management opened 2 new positions and closed 12 in Q4 2017.
- Reynders McVeigh Capital Management's portfolio value fell 0.51% quarter-over-quarter to $763M.
Based on Reynders McVeigh Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.